Back to Agenda
Pharmacovigilance and Post Market Surveillance
Session Chair(s)
Milos Stojkovic, MPharm
Safety Process Director, Pharmacovigilance & Scientific Development
F. Hoffmann-La Roche Ltd, Switzerland
Many things have changed since the 1960s and the events that institutionalised (pharmaco)vigilance as we know it today. While the focus on public safety might not have changed, ways of achieving this goal as well as processes and the people behind them, as well as their professional perception have come a long way. In this session we will present what is pharmacovigilance and post market surveillance today, touching upon drugs and medical devices and sharing perspectives from professional with different levels of experience. Speakers will not only present to you different parts of vigilance, but will also present you their career progressions which brought them in the roles they are today. In the end the panel will be open for your questions and will look where pharmacovigilance is headed in the future.
Speaker(s)
Speaker
Michelle Grimes, MSc
MSD, United Kingdom
Head, International Pharmacovigilance. GCS&PV
Speaker
Arton Baftiu, PharmD
Norwegian Medicines Agency, Norway
Scientific Officer
Have an account?